AnaptysBio (ANAB) Q3 2021 Earnings Report
0 Followers
MX:ANAB Q3 2021 EPS Results
- Actual EPS
- -MXN 4.49
- Consensus EPS
- -MXN 15.92
- Beat/Miss
- Beat by +MXN 11.42
- One Year Ago EPS
- -MXN 16.29
MX:ANAB Q3 2021 Revenue Results
- Actual Revenue
- MXN 391.20M
- Expected Revenue
- MXN 124.61M
- Beat/Miss
- Beat by +MXN 266.59M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/04/2021
- Time
- After Close
- Conference Call
- Thursday, November 4, 2021
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -34.46-34.46 | 9.76 | -453.17% (-44.21) | ― |
| Sep 21, 2026 | 2026 (Q2) | -16.72-16.72 | -16.72 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.50-15.97 | -24.03 | 33.52% (+8.05) | |
| Mar 03, 2026 | 2025 (Q4) | -16.7229.64 | -8.99 | 429.79% (+38.63) | |
| Nov 04, 2025 | 2025 (Q3) | -15.979.76 | -14.23 | 168.55% (+23.99) | |
| Aug 06, 2025 | 2025 (Q2) | -8.99-25.11 | -21.35 | -17.63% (-3.76) | |
| May 05, 2025 | 2025 (Q1) | -14.23-24.03 | -20.47 | -17.38% (-3.56) | |
| Feb 27, 2025 | 2024 (Q4) | -20.21-8.99 | -19.85 | 54.72% (+10.86) | |
| Nov 05, 2024 | 2024 (Q3) | -20.56-14.23 | -17.6 | 19.15% (+3.37) | |
| Aug 05, 2024 | 2024 (Q2) | -13.00-21.35 | -18.73 | -14.00% (-2.62) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
